Microcurrent Stimulation to Treat Macular Degeneration

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Noninvasive Brain Stimulation in Adult Amblyopia

NCT06712849

Amblyopia

RECRUITING NA

Clinical Treatment of Transcranial Direct Current Stimulation in Older Adolescents With Amblyopia

NCT06760910

Amblyopia

RECRUITING NA

Eye-tracking Based Amblyopia Training

NCT05078099

Amblyopia

COMPLETED NA

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

NCT01982383

Central Serous Chorioretinopathy

TERMINATED NA

Improving Vision in Adults With Macular Degeneration

NCT04111068

Macular Degeneration

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Diseases Stargardt's Disease Retinitis Pigmentosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to provide written consent and comply with follow up visits
* Age 40 years or older
* ETDRS best corrected visual acuity better than 5 letters
* History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease
* No Anti-VEGF treatments for at least 3 months prior to study
* No new antioxidant/vitamin supplementation for at least 3 months prior to study

Exclusion Criteria

* History of Non-Compliance with regular medical visits
* Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity
* Presence of pigment epithelial tears or rips
* Known serious allergies to fluorescein dye
* Presence of retinal neovascularization
* Any treatment with an investigation agent in the past 30 days

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes